Advanced search
Publication Cover
Acta Obstetricia et Gynecologica Scandinavica Volume 83, 2004 - Issue 6
Journal homepage
6
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Pulmonary embolism associated with combined oral contraceptives: reporting incidences and potential risk factors for a fatal outcome

Karin Hedenmalm Pharmacovigilance Unit, Medical Products Agency, Uppsala, Sweden
,
Eva Samuelsson Pharmacovigilance Unit, Medical Products Agency, Uppsala, Sweden
&
Olav Spigset Pharmacovigilance Unit, Medical Products Agency, Uppsala, Sweden
Pages 576-585 | Published online: 10 Aug 2009

References

  • Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet 1999; 353: 1167–73.
  • Bottiger LE, Boman G, Eklund G, Westerholm B. Oral contraceptives and thromboembolic disease: effects of lowering oestrogen content. Lancet 1980; 1: 1097–101.
  • Stolley PD, Tonascia JA, Tockman MS, Sartwell PE, Rutledge AH, Jacobs MP. Thrombosis with low-estrogen oral contraceptives. Am J Epidemiol 1975; 102: 197–208.
  • Gerstman BB, Piper JM, Tomita DK, Ferguson WJ, Stadel BV, Lundin FE. Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease. Am J Epidemiol 1991; 133: 32–7.
  • Bloemenkamp KW, Rosendaal FR, Helmerhorst FM, Buller HR, Vandenbroucke JP. Enhancement by factor V Leiden mutation of risk of a deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen. Lancet 1995; 346: 1593–6.
  • Rosendaal FR, Helmerhorst FM, Vandenbroucke JP. Female hormones and thrombosis. Arterioscler Thromb Vasc Biol 2002; 22: 201–10.
  • Odlind V, Milsom I, Persson I, Victor A. Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills? Acta Obstet Gynecol Scand 2002; 81: 482–90.
  • Kemmeren JM, Algra A, Grobbee DE. Third generation oral contraceptives and risk of venous thrombosis: meta-analysis. BMJ2001; 323: 131–4.
  • Vasilakis-Scaramozza C, Jick H. Risk of venous thromboembolism with cyproterone or levonorgestrel contraceptives. Lancet 2001; 358: 1427–9.
  • Jick H, Jick SS, Gurewich V, Myers MW, Vasilakis C. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components. Lancet 1995; 346: 1589–93.
  • Parkin L, Skegg DC, Wilson M, Herbison GP, Paul C. Oral contraceptives and fatal pulmonary embolism. Lancet 2000; 355: 2133–4.
  • Fotherby K. A metabolic assessment of different oral contraceptives. J Obstet Gynaecol 1983; 3: S77–S82.
  • Goldhaber SZ. Pulmonary embolism. N Engl J Med 1998; 339: 93–104.
  • Kearon C. Diagnosis of pulmonary embolism. CMAJ 2003; 168: 183–94.
  • Turpie AG, Chin BS, Lip GY. Venous thromboembolism. pathophysiology, clinical features, and prevention. BMJ 2002; 325: 887–90.
  • Gorman WP, Davis KR, Donnelly R. ABC of arterial and venous disease. Swollen lower limb-1: general assessment and deep vein thrombosis. BMJ 2000; 320: 1453–6.
  • Egermayer P. Obesity, oral contraceptives, and fatal pulmonary embolism. N Z Med J 2001; 114: 170–1.
  • World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. Lancet 1995; 346: 1575–82.
  • Vessey MP, Doll R. Investigation of relation between use of oral contraceptives and thromboembolic disease. A further report. BMJ 1969; 2: 651–7.
  • Farmer RD, Lawrenson RA, Todd JC, Williams TJ, MacRae KD, Tyrer F et al. A comparison of the risks of venous thromboembolic disease in association with different combined oral contraceptives. Br J Clin Pharmacol 2000; 49: 580–90.
  • Lidegaard O, Edstrom B, Kreiner S. Oral contraceptives and venous thromboembolism. A case-control study. Contraception 1998; 57: 291–301.
  • Hägg S, Spigset O. Antipsychotic-induced venous thromboembolism. A review of the evidence. CNS Drugs 2002; 16: 765–76.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.